Transformation of nanocrystalline Mg(OH) 2 to MgO under dynamic vacuum in a temperature range of 570-770 K was studied by TGA-GCMS, FTIR, HREM, XRD, helium pycnometry, and nitrogen adsorption at 77 K. Several processes are shown to occur during transformation including: (a) release of compounds chemisorbed during preparation of nanocrystalline Mg(OH) 2 simultaneously with hydroxide-oxide transformation; (b) fragmentation of nanoparticles at temperatures lower than 670 K; and (c) re-crystallization and sintering of nanoparticles, whose mean size increases and relative number decreases rapidly with temperature above 670 K. A new phenomenon of decrease of the interlayer distance in MgO crystallites with increase of the nanoparticle size was observed.
IntroductionThe transformation of Mg(OH) 2 prepared from different precursors to the corresponding MgO during thermal treatment was studied extensively in the past (see, e.g., ref 1 and the references within). Conventionally prepared magnesium hydroxide has the structure of hexagonal, smooth crystalline platelets with a size of 10-100 nm. The specific surface area is typically about 10-70 m 2 /g and the volume of pores is in the range of 0.1-0.7 cm 3 /g. Decomposition at 500-600 K results in pseudomorphous transformation of each single platelet, thus the newly appeared numerous MgO crystals of much smaller size (5-20 nm) form a porous aggregate of the same volume and shape the original platelet had. Thus, porous MgO aggregates appear from nonporous Mg(OH) 2 platelets. Increase of a treatment temperature results in sintering of MgO crystals (decrease in their relative number and increase in size).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.